Although the encapsulated Staphylococcus aureus Smith diffuse strain was isolated in 1930, the production of exopolysaccharides by clinical S. aureus isolates is controversial (7, 12) . Marrie et al. (8) (9) (10) used electron microscopy to demonstrate extensive exopolysaccharide deposition surrounding S. aureus infections of pacemaker leads, peritoneal dialysis catheters, and intravascular devices. The techniques used for screening S. aureus isolates for exopolysaccharide production previously depended upon the serum-soft agar technique (14, 15) and immunoelectrophoresis (6) . We (13) recently reported an antiserum agar method for use in detecting exopolysaccharide production by S. aureus. Similar antiserum agar methods are now employed for serogrouping Neisseria meningitidis and other encapsulated organisms (1, 2) . In the present investigation we used the antiserum agar method to screen clinical isolates of S. aureus for the production of an exopolysaccharide antigenically identical to the exopolysaccharide by the S. aureus Smith diffuse strain. Type strain and production of antisera. The S. aureus Smith diffuse strain and the nonencapsulated variant Smith compact strain were obtained from M. Ann Melly, Vanderbilt University, Nashville, Tenn. Antiserum to the Smith diffuse strain was produced in rabbits (11) . The immunization schedule consisted of three series of 3 successive days of intravenous injections (108 to 109 CFU) of Formalin-killed whole bacteria into the marginal ear veins of rabbits. Each series was separated from the previous by an interval of 5 days. The rabbits were bled 7 days after the last inoculation.
MATERIALS AND METHODS
Preparation of antiserum agar plates. The Smith diffuse antiserum was heat inactivated at 60°C for 30 min and filter sterilized. Columbia broth (Difco) was supplemented with 0.5% agarose (Litex, Denmark), 1 
DISCUSSION
The S. aureus Smith diffuse strain was isolated from a patient with osteomyelitis in 1930 and was not described until 1956 (12) . The strain attracted laboratory attention because of its unique capacity for virulence after mouse intraperitoneal inoculation (5). Koenig (7) later isolated an avirulent variant (Smith compact strain) and demonstrated that the virulence of the Smith diffuse strain was related to the presence of an exopolysaccharide that the variant lacked.
Although these observations on the virulence of the two Smith strains were exciting, the clinical significance of exopolysaccharide production by S. aureus remains controversial. Early investigations into exopolysaccharide produced by S. aureus was based on the serum-soft agar technique described by Finkelstein and Sulken (3) . Their basal medium consisted of 0.15% agar with 1.0% normal serum. Strains producing an exopolysaccharide when suspended in this medium produced a characteristic diffuse colonial morphology as compared with their nonproducing variant's compact colonial morphology. Yoshida (14) found that specific antiserum in the serum-soft agar technique would convert a diffuse colonial morphology to compact and therefore allow the demonstration of different antigenic types of exopolysaccharides. Although the exact mechanism responsible for the differences in the colonial morphology of exopolysaccharide producing S. aureus on serum-soft agar is not certain, an antigen-antibody precipitin reaction is not involved (3).
Yoshida (14) strain, when cultured on this medium again lacked a surrounding precipitin halo.
Our investigation was limited to the detection of exopolysaccharides antigenically identical to the well-known S. aureus Smith diffuse strain. We found that 64.3% of 140 clinical S. aureus isolates produced an antigenically identical exopolysaccaride. The addition of antiserum agar to other antigenically diverse S. aureus exopolysaccharides may further increase the percentage of clinical exopolysaccharide producing S. aureus detected. Our results with the antiserum agar method with antiserum to the Smith diffuse strain suggest that the production of exopolysaccharides by clinical strains of S. aureus is a common phenomenon. Further investigations may determine the utility of S. aureus typing systems based upon the antigenic type of exopolysaccharide.
